142 related articles for article (PubMed ID: 31413430)
1. Immunohistochemical Expression of Vimentin in Invasive Breast Carcinoma and Its Correlation with Clinicopathological Parameters.
Khillare CD; Sinai Khandeparkar SG; Joshi AR; Kulkarni MM; Gogate BP; Battin S
Niger Med J; 2019; 60(1):17-21. PubMed ID: 31413430
[TBL] [Abstract][Full Text] [Related]
2. Stromal expression of CD10 in breast carcinoma and its correlation with clinicopathological parameters.
Dhande AN; Sinai Khandeparkar SG; Joshi AR; Kulkarni MM; Pandya N; Mohanapure N; Aggarwal A; Patil G
South Asian J Cancer; 2019; 8(1):18-21. PubMed ID: 30766845
[TBL] [Abstract][Full Text] [Related]
3. Study of ER, PR, HER2/neu, p53, and Ki67 expression in primary breast carcinomas and synchronous metastatic axillary lymph nodes.
Khande TA; Joshi AR; Khandeparkar SGS; Kulkarni MM; Gogate BP; Kakade AR; Sahu PD; Khillare CD
Indian J Cancer; 2020; 57(2):190-197. PubMed ID: 32445323
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of cyclin D1 in invasive breast carcinoma and its correlation with clinicopathological parameters.
Lengare PV; Sinai Khandeparkar SG; Joshi AR; Gogate BP; Solanke SG; Gore SH
Indian J Pathol Microbiol; 2020; 63(3):376-381. PubMed ID: 32769325
[TBL] [Abstract][Full Text] [Related]
5. Mucinous Breast Carcinoma: Clinicopathological Comparison With Invasive Ductal Carcinoma.
Hashmi AA; Zia S; Yaqeen SR; Ahmed O; Asghar IA; Islam S; Afzal A; Irfan M; Zia F; Ali J
Cureus; 2021 Mar; 13(3):e13650. PubMed ID: 33824803
[TBL] [Abstract][Full Text] [Related]
6. Association of Histopathological Markers with Clinico- Pathological Factors in Mexican Women with Breast Cancer.
Bandala C; De la Garza-Montano P; Cortes-Algara A; Cruz-Lopez J; Dominguez-Rubio R; Gonzalez-Lopez JN; Cardenas-Rodriguez N; Alfaro-Rodriguez A; Salcedo M; Floriano-Sanchez E; Lara-Padilla E
Asian Pac J Cancer Prev; 2015; 16(18):8397-403. PubMed ID: 26745092
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical evaluation of lymphovascular invasion in carcinoma breast with CD34 and D2-40 and its correlation with other prognostic markers.
Agarwal S; Singh A; Bagga PK
Indian J Pathol Microbiol; 2018; 61(1):39-44. PubMed ID: 29567882
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Immunohistochemical Profile of Breast Cancer for Prognostics and Therapeutic Use.
Chand P; Garg A; Singla V; Rani N
Niger J Surg; 2018; 24(2):100-106. PubMed ID: 30283220
[TBL] [Abstract][Full Text] [Related]
9. Invasive Papillary Carcinoma of the Breast: Clinicopathological Features and Hormone Receptor Profile.
Hashmi AA; Munawar S; Rehman N; Ahmed O; Islam S; Asghar IA; Afzal A; Irfan M; Shamail F; Ali SJ
Cureus; 2021 Feb; 13(2):e13480. PubMed ID: 33777568
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical study of epidermal growth factor receptor, human epidermal growth factor receptor 2/neu, p53, and Ki67 in oral squamous cell carcinoma.
Mohanapure NS; Khandeparkar SGS; Saragade PB; Gogate BP; Joshi AR; Mehta SR
J Oral Maxillofac Pathol; 2022; 26(1):127-128. PubMed ID: 35571320
[TBL] [Abstract][Full Text] [Related]
11. Joint detection of multiple immunohistochemical indices and clinical significance in breast cancer.
Qiao EQ; Ji M; Wu J; Li J; Xu X; Ma R; Zhang X; He Y; Zha Q; Song X; Zhu L; Tang JH
Mol Clin Oncol; 2013 Jul; 1(4):703-710. PubMed ID: 24649232
[TBL] [Abstract][Full Text] [Related]
12. Ki67 expression in breast cancer. Correlation with prognostic markers and clinicopathological parameters in Saudi patients.
Elkablawy MA; Albasri AM; Mohammed RA; Hussainy AS; Nouh MM; Alhujaily AS
Saudi Med J; 2016 Feb; 37(2):137-41. PubMed ID: 26837394
[TBL] [Abstract][Full Text] [Related]
13. Male breast carcinoma: correlation of ER, PR, Ki-67, Her2-Neu, and p53 with treatment and survival, a study of 65 cases.
Wang-Rodriguez J; Cross K; Gallagher S; Djahanban M; Armstrong JM; Wiedner N; Shapiro DH
Mod Pathol; 2002 Aug; 15(8):853-61. PubMed ID: 12181271
[TBL] [Abstract][Full Text] [Related]
14. Stromal Expression of CD10 in Invasive Breast Carcinoma and Its Correlation with ER, PR, HER2-neu, and Ki67.
Puri V; Jain M; Thomas S
Int J Breast Cancer; 2011; 2011():437957. PubMed ID: 22295223
[TBL] [Abstract][Full Text] [Related]
15. Comparison of ER, PR and HER-2/neu (C-erb B 2) reactivity pattern with histologic grade, tumor size and lymph node status in breast cancer.
Azizun-Nisa ; Bhurgri Y; Raza F; Kayani N
Asian Pac J Cancer Prev; 2008; 9(4):553-6. PubMed ID: 19256737
[TBL] [Abstract][Full Text] [Related]
16. Pattern of hormone receptors and human epidermal growth factor receptor 2 status in sub-Saharan breast cancer cases: Private practice experience.
Nwafor CC; Keshinro SO
Niger J Clin Pract; 2015; 18(4):553-8. PubMed ID: 25966732
[TBL] [Abstract][Full Text] [Related]
17. Ki67 index in breast cancer: correlation with other prognostic markers and potential in pakistani patients.
Haroon S; Hashmi AA; Khurshid A; Kanpurwala MA; Mujtuba S; Malik B; Faridi N
Asian Pac J Cancer Prev; 2013; 14(7):4353-8. PubMed ID: 23992002
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical Expression of BRCA1 Protein, ER, PR and Her2/neu in Breast Cancer: A Clinicopathological Study.
Hussein IA; Ahmed ST; Hameedi AD; Naji RZ; Alharbawi L; Alkhaytt M; Pity IS
Asian Pac J Cancer Prev; 2020 Apr; 21(4):1025-1029. PubMed ID: 32334465
[TBL] [Abstract][Full Text] [Related]
19. Marked lymphovascular invasion, progesterone receptor negativity, and high Ki67 labeling index predict poor outcome in breast cancer patients treated with endocrine therapy alone.
Kurebayashi J; Kanomata N; Shimo T; Yamashita T; Aogi K; Nishimura R; Shimizu C; Tsuda H; Moriya T; Sonoo H
Breast Cancer; 2014 Mar; 21(2):214-22. PubMed ID: 22689016
[TBL] [Abstract][Full Text] [Related]
20. Hormonal Receptor, Human Epidermal Growth Factor and Its Association with Breast Cancer Tumor Characteristics in Albania.
Pajenga E; Rexha T; Çeliku S; Ugrinska A; Bejtja G
Cent Eur J Public Health; 2016 Sep; 24(3):171-175. PubMed ID: 27760283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
